Efferon

Austria · Biotech · Healthtech

Efferon develops blood-purification devices that remove endotoxins and excessive inflammatory mediators for critical care.

Product

Efferon develops single-use hemoadsorption devices for extracorporeal blood purification in critical care. Its technology is designed to remove bacterial endotoxins and excessive inflammatory mediators from the bloodstream.

The company offers Efferon LPS for adults and Efferon NEO for paediatric patients. Headquartered in Austria with manufacturing in Latvia, it supplies hospitals through an international distributor network.

Funding history

2 rounds · 2 with disclosed amounts
AnnouncedRoundAmountInvestors
Undisclosed€4.3MParticipants not disclosed
Seed€2.5MParticipants not disclosed
Sourcesefferon.com ↗